Abiomed sued again; Hospira a rumored takeover candidate;

 @FierceMedDev: Exosome draws $5M in financing for molecular Dx work. Item | Follow @FierceMedDev

 @MarkHFierce: House Majority Leader Eric Cantor has revived the device tax repeal push, as part of Republicans' new platform. Story | Follow @MarkHFierce

 @DamianFierce: Allergan is looking to sell off its Lap-Band business as revenues continue to plummet. News | Follow @DamianFierce

> The lawsuits are growing against Abiomed ($ABMD), accusing the company and its executives of concealing alleged improper marketing of its Impella 2.5 heart pump, and artificially inflating its stock price as a result. Story

> Hospira ($HSP), a maker of infusion pumps and generic drugs, may be a takeover candidate. Story

> EClinicalWorks is devoting $25 million to launch a new mobile health business unit that will focus on engaging patients in order to boost quality and lower costs. Story

> Smiths Medical won FDA clearance for its CADD-Solis VIP ambulatory infusions system equipped with CADD-Solis medication safety software. Release

> Arizona's bioscience sector--which is dominated, in part, by medical device jobs--is growing at four times the national rate. Story

> Scientists are testing specialized glasses based on a new color vision theory to help patients with red-green color blindness. Story

> Guided Therapeutics snatched up global rights from Konica Minolta to develop a non-invasive esophageal cancer detection device based on its own biophotonic technology platform. Release

Biotech News

 @FierceBiotech: Pfizer partner Protalix soars on sale speculation. Report | Follow @FierceBiotech

@JohnCFierce: So Elan has $3.25B to play with? Will they blow it? Analysis | Follow @JohnCFierce

@RyanMFierce: No surprise here. HISUN doesn't want exclusive license to Celsion's ThermoDox for the China market. Release | Follow @RyanMFierce

> Catabasis raises $9M for PhII-ready drug development program. News

> Ipsen, insolvent biotech partner find buyer for troubled hemophilia drug. Report

Pharma News

@FiercePharma: GSK to hack jobs in Europe where austerity has taken toll. Report | Follow @FiercePharma

@EricPFierce: With sale of Tysabri rights to Biogen Idec, Elan is now flush with cash and looking for something to buy. News | Follow @EricPFierce

@AlisonBFierce: Merck and GlaxoSmithKline will work with the GAVI Alliance to provide low-cost HPV vaccines to developing countries. Article | Follow @AlisonBFierce

> Merck loses 'bellwether' Fosamax case. Article

> Is Hospira primed for a takeover? News

Drug Delivery News

> Cloaked nanoparticles look like blood cells, carry drugs. Story

> FDA to review BTG's varicose vein foam injection. News

> Rockwell shows iron delivery drug for dialysis improves treatment. Article

> Langer's Kala scores Cystic Fibrosis Foundation grant. Report

Biomarkers News

> Brain biomarker may help open door to personalized depression drugs. Report

> FDA will make use of GVK biomarker database. Item

> Biomarker could be key to MS Dx and targeted treatment. Article

> Molecules that could predict cancer growth detected. News

> Researcher names protein as plausible autism biomarker. Story

BD&L Summit

Deal-Making Insights for the Life Sciences Industry

Bringing together key deal-makers and serving as an open forum for cross-functional business development and legal teams to share valuable insights and actionable strategies on successfully managing alliances, licensing agreements, and M&A deals.